Astria Therapeutics, Inc. ( ATXS) - Key Metrics
Stock symbol ATXS is outdated, potentially delisted? Maybe it is available on other exchange?
ATXS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | ? | -$0.57 | -$0.62 | -$0.63 |
| 2025Q1 | ? | -$0.58 | -$0.59 | -$0.59 |
| 2024Q4 | ? | -$0.45 | -$0.31 | -$0.31 |
| 2024Q3 | ? | -$0.43 | -$0.50 | -$0.50 |
| 2024Q2 | ? | -$0.43 | -$0.30 | -$0.30 |
ATXS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -2.35 |
| 2025Q1 | ? | -2.30 |
| 2024Q4 | ? | -4.92 |
| 2024Q3 | ? | -6.34 |
| 2024Q2 | ? | -5.40 |
ATXS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q2 | -11.79% | ? |
| 2025Q1 | -10.98% | ? |
| 2024Q4 | -3.44% | ? |
| 2024Q3 | -4.50% | ? |
| 2024Q2 | -3.27% | ? |
ATXS
Price: $12.58
52 week price:
Earnings Per Share: -2.14 USD
P/E Ratio: -5.99
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 121600
Market Capitalization: 731.8 million